The largest database of trusted experimental protocols

Bm mscs

Manufactured by PromoCell
Sourced in Germany

BM-MSCs are bone marrow-derived mesenchymal stem cells, which are a type of multipotent stem cell that can differentiate into various cell types, including osteoblasts, chondrocytes, and adipocytes. They are isolated from bone marrow and are commonly used in research and clinical applications.

Automatically generated - may contain errors

9 protocols using bm mscs

1

Expansion of Placental Pericytes and Bone Marrow Mesenchymal Stromal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Placental pericytes (Pl-PCs; PromoCell) and bone marrow derived mesenchymal stromal cells (BM-MSCs; PromoCell) were thawed and seeded into untreated/uncoated flasks. Pl-PCs were seeded at a density of 3–4 × 104 cells per cm2 into 1 T-150 flask. Pl-PCs were cultured and expanded in Pericyte Growth Medium (PromoCell). BM-MSCs were seeded at a density of 4 × 104 cells per cm2 into 1 T-150 flask. BM-MSCs were cultured and expanded in Mesenchymal Stem Cell Growth Medium (PromoCell). Both Pl-PC and BM-MSC cultures were fed once every 2–3 days and cells passaged at 80–90% confluency.
+ Open protocol
+ Expand
2

Isolation and Characterization of Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human bone marrow derived mesenchymal stem cells (bm-MSCs) were purchased from Promocell at Passage 2 and were cultured with MSC Growth Medium 2 (Promocell). Cells were plated in T75 flasks at a density of 4000 cells/cm2. Cells were cultured in incubators at 37 °C and 5% CO2. Cell culture medium was changed every other day. Cells were passaged when 80–90% confluency was reached, using Accutase solution (Promocell) for detachment. Cells of passage 3 to 6 were used for experiments.
Human amnion-derived mesenchymal stem cells (ha-MSC) were provided by Dr. Kenichi Yamahara [40 ]. Their marker expression (positive for CD73 and CD29, negative for CD45 and CD34), as well as their ability to differentiate into adipocytes and osteocytes, at least up to passage 20, was previously established in our lab [9 (link)]. Cells were defrosted from cryopreservation vials at Passage 10 and seeded in T75 flasks at a density of 10,000 cells/cm2, and cultured in aMEM (Gibco) with 10% fetal bovine serum (FBS), supplemented with 1% penicillin and streptomycin and 10% of human basic fibroblast growth factor (bFGF, 10 ng/mL). Cells were cultured in incubator at 37 °C and 5% CO2. Cell culture medium was changed every other day. Cells were passaged when at 80%–90% confluency by detachment using 0.25% Trypsin with 0.2% EDTA (Sigma). Passage 11 to 14 cells were used for experiments.
+ Open protocol
+ Expand
3

Isolation and Culture of MSCs from Various Sources

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human MSCs derived from umbilical cord (UC-MSCs) and bone marrow (BM-MSCs) were obtained from PromoCell (Heidelberg, Germany). Human adipose tissue-derived MSCs (AD-MSCs) were obtained from Lonza (Basel, Switzerland). All cells were cultured in standard culture medium comprising Dulbecco's modified Eagle's medium (DMEM) (Gibco, Rockville, MD, USA) supplemented with 10% fetal bovine serum (FBS) (BIOSERA, Ringmer, UK), 1% GlutaMAX (Gibco), 1% MEM non-essential amino acids (Gibco), 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco). The cells were cultured at 37 °C under 5% CO2 in a humidified chamber and passaged upon reaching confluency. For passaging, the cells were treated with cell dissociation buffer (TrypLE; Gibco) for 5 min and subcultured in standard culture medium at 4000 cells/cm2. Cells at passages 3 (BM-MSCs) and 4 (UC-MSCs, AD-MSCs) were used.
+ Open protocol
+ Expand
4

Derivation and Characterization of MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PSC-MSCs were derived and characterized as previously reported [10 (link)]. ES-MSCs were derived from HSF-6 (University of California, San Francisco) and H1 (Wisconsin Alumni Research Foundation) [46 (link), 47 (link)]. iPS-MSCs were derived from iPS which were generated by two methods: (1) Sendai Virus induction (Sendai Reprogramming Kit; Invitrogen-Thermo Fisher Scientific, MA, USA) with all four Yamanaka factors into human peripheral blood mononuclear cells as per manufacturer's and published protocols [48 (link)] for iPS-MSC clones 1 and 2; and (2) lentiviral induction with Oct-4 and Sox-2 into human umbilical vein endothelial cells (Bioresource Collection and Research Center, Hsinchu, Taiwan) as previously reported [49 (link)] for iPS-MSC clone 3. BM-MSCs were obtained commercially (Promocell, Heidelberg, Germany) and cultured as previously described [4 (link)]. All MSCs were cultured with complete medium consisting of DMEM-low glucose supplemented with 1% penicillin/streptomycin, 1% L-glutamine (all from Gibco-Thermo Fisher Scientific), and 10% fetal bovine serum (FBS, selected lots from Hyclone-Thermo Fisher Scientific) and expanded as previously described [10 (link)].
+ Open protocol
+ Expand
5

Culturing diverse cell lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines of liver hepatocellular carcinoma (HepG2, PromoCell, USA), human bone marrow mesenchymal stromal cells (BM-MSCs) (PromoCell, USA), human umbilical cord mesenchymal stromal cells (UC-MSCs) (PromoCell, USA) were cultured in a culture medium consists of high glucose DMEM (Sigma, Tokyo, Japan), 10% fetal bovine serum (FBS) (CCB, NICHIREI BIOSCIENCE, Tokyo, Japan) and 1% penicillin/streptomycin (Life Technology, Carlsbad, CA, USA) while human umbilical vein endothelial cells (HUVECs) (Lonza, USA) were cultured in endothelial cell culture medium (EBM) (EGM, Lonza, Tokyo, Japan) containing 2% FBS and vascular endothelial growth factor (VEGF). Cells were then incubated at 37°C in a humidified atmosphere containing 5% CO2 and 95% air.
+ Open protocol
+ Expand
6

Derivation and Expansion of Human MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSC-MSCs were derived from iPSCs generated from fetal endothelial cells through lentiviral transduction of OCT-4 and SOX-2,56 (link) and human ESC-MSCs were derived from H1 (Wisconsin Alumni Research Foundation, Madison, WI, USA) with medium consisted of DMEM-low glucose, 1% penicillin/streptomycin and 10% fetal bovine serum.5 (link),7 (link),57 (link) BM-MSCs were obtained from commercial sources (Promocell, Heidelberg, Germany). All MSCs were cultured and expanded in low-glucose Dulbecco’s Modified Eagle’s medium (DMEM) (Gibco-Thermo Fisher Scientific, MA, USA), with 10% FBS (Hyclone-Thermo Fisher Scientific) and 100 U/mL penicillin, 100 g/mL streptomycin, and 2 mM L-glutamine (all from Gibco-Thermo Fisher Scientific).3 (link),58 (link)
+ Open protocol
+ Expand
7

Characterization of Cancer and Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cancer cell lines used included: OVCAR-3-NIH (ovarian) and KATO-III (gastric) purchased from ATCC®. Adult human mesenchymal stem cells (BM-MSCs; derived from bone marrow) obtained from ‘PromoCell GmbH’ were used as control (normal healthy stem cells). The cell lines were chosen based on expression of the CD90 stem cell marker, and immune checkpoint molecules, PD-L1 and HLA-G. Each cell line was maintained in medium specified by the provider at 37°C in a humidified chamber maintained with 5% CO2. The media used were RPMI-1640 for OVCAR-3-NIH, IMDM for KATO-III each supplemented with 10% fetal bovine serum (FBS), 1% pencillin-streptomycin and 1% L-glutamine (Gibco; Thermo Fisher Scientific, Inc.), while specialized Mesenchymal Stem Cell Medium from PromoCell was used for the BM-MSCs. All cell lines used were of low passages (less than 7 passages) to maintain pluripotency.
+ Open protocol
+ Expand
8

Characterization of Human MSCs from Bone Marrow and Adipose Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human bone marrow-derived (BM-MSCs; passage 2) and adipose tissue-derived MSCs (AD-MSCs; passage 2) were obtained from PromoCell (Heidelberg, Germany; C-12977). The cells were expanded through passage 4 in StemPro MSC SFM XenoFree medium (Thermo Fisher Scientific, Waltham, MA, USA) under hypoxic (5 %) conditions in the presence of 5 % CO2 at 37 °C.
The morphology, proliferation potential, adherence rate, and viability of the cells were tested using PromoCell. The cells were analyzed by flow cytometry using a comprehensive panel of markers, CD73/CD90/CD105 and CD14/CD19/CD34/CD45/HLA-DR. Adipogenic, osteogenic, and chondrogenic differentiation assays were performed for each lot in the absence of antibiotics and antimycotics.
+ Open protocol
+ Expand
9

Culturing Human Cells for Comparative Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human TSCs were obtained from American Type Culture Collection (ATCC) (HTR8-SVneo, CRL-3271; VA, USA) and cultured in RPMI-1640 (Gibco) supplemented with 5% FBS (Gibco) and 1% penicillin/streptomycin (10,000 U/mL) (Gibco) at 37 °C with 5% CO2. The human MSCs used in this study, including bone marrow-derived MSCs (BM-MSCs), umbilical cord-derived MSCs (UC-MSCs), and adipose tissue-derived MSCs (AD-MSCs), were purchased from PromoCell (PromoCell; Heidelberg, Germany). All cells were grown in MEM (Gibco) medium supplemented with 5% FBS and 1% penicillin/streptomycin (10,000 U/mL) (Gibco) was used for cell culture. Serum-free medium (SFM) indicates FBS-excluded growth medium, which does not contain animal-derived materials. All cells were maintained in a humidified atmosphere at 37 °C with 5% CO2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!